Hirtle Callaghan & Co’s Viatris VTRS Stock Holding History

Hirtle Callaghan & Co’s Portfolio VTRS Stock Details VTRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-83,861	Closed	-$933K	–	107
2022 Q4	$933K	Hold	83,861	–	–	0.06%	76
2022 Q3	$714K	Buy	+83,861	New	+$825K	0.05%	78
2016 Q4	–	Sell	-15,000	Closed	-$572K	–	203
2016 Q3	$572K	Hold	15,000	–	–	0.12%	49
2016 Q2	$649K	Hold	15,000	–	–	0.12%	42
2016 Q1	$696K	Buy	+15,000	New	+$724K	0.13%	40
2015 Q1	–	Sell	-15,000	Closed	-$846K	–	361
2014 Q4	$846K	Hold	15,000	–	–	0.2%	77
2014 Q3	$682K	Hold	15,000	–	–	0.11%	89
2014 Q2	$773K	Hold	15,000	–	–	0.11%	112
2014 Q1	$732K	Hold	15,000	–	–	0.12%	104
2013 Q4	$651K	Hold	15,000	–	–	0.09%	114
2013 Q3	$573K	Buy	+15,000	New	+$528K	0.09%	118

Other funds holding VTRS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Hirtle Callaghan & Co's VTRS Position: Q1 2023 in Review

Hirtle Callaghan & Co sold out of Viatris (VTRS) in Q1 2023, closing a stake of 83,861 shares — an estimated $933K sold.

Hirtle Callaghan & Co first reported a position in VTRS in Q3 2013 and held it in 11 quarters. The position peaked at $933K in Q4 2022. 990 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

Hirtle Callaghan & Co reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
Hirtle Callaghan & Co sold 83,861 Viatris shares in Q1 2023, an estimated $933K.
Hirtle Callaghan & Co first reported a position in Viatris in Q3 2013 and held it in 11 quarters.
Hirtle Callaghan & Co's Viatris position peaked at $933K in Q4 2022.
990 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2023, filed 11 May 2023.